Rongchang Bio (688331.SH) announced a pre-profit warning, expecting a net profit attributable to the parent company of approximately 4.7 billion yuan for the half-year, turning losses into profits.

Zhuhang Finance APP reported that Rongchang Biologics (688331.SH) announced that the company expects to achieve a net profit attributable to shareholders of the parent company of approximately 4.7 billion yuan for the first half of 2026, turning a profit compared to the same period last year.